Skip to Content
Merck
  • Developing structure-activity relationships for the prediction of hepatotoxicity.

Developing structure-activity relationships for the prediction of hepatotoxicity.

Chemical research in toxicology (2010-06-18)
Nigel Greene, Lilia Fisk, Russell T Naven, Reine R Note, Mukesh L Patel, Dennis J Pelletier
ABSTRACT

Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems. This process can be supported by the use of existing toxicity data and mechanistic understanding of the biological processes for related compounds. In the published literature, this information is often spread across diverse sources and can be varied and unstructured in quality and content. The current work has explored whether it is feasible to collect and use such data for the development of new SARs for the hepatotoxicity endpoint and expand upon the limited information currently available in this area. Reviews of hepatotoxicity data were used to build a structure-searchable database, which was analyzed to identify chemical classes associated with an adverse effect on the liver. Searches of the published literature were then undertaken to identify additional supporting evidence, and the resulting information was incorporated into the database. This collated information was evaluated and used to determine the scope of the SARs for each class identified. Data for over 1266 chemicals were collected, and SARs for 38 classes were developed. The SARs have been implemented as structural alerts using Derek for Windows (DfW), a knowledge-based expert system, to allow clearly supported and transparent predictions. An evaluation exercise performed using a customized DfW version 10 knowledge base demonstrated an overall concordance of 56% and specificity and sensitivity values of 73% and 46%, respectively. The approach taken demonstrates that SARs for complex endpoints can be derived from the published data for use in the in silico toxicity assessment of new compounds.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Carbendazim, 97%
Pricing and availability is not currently available.
Supelco
3-Methylcholanthrene, analytical standard
Pricing and availability is not currently available.
Aflatoxin B1 solution, 3.79 μg/g in acetonitrile, ERM®, certified reference material
Pricing and availability is not currently available.
Sigma-Aldrich
Quinine, 90%
Pricing and availability is not currently available.
Sigma-Aldrich
3-Methylcholanthrene, 98%
Pricing and availability is not currently available.
Supelco
Betamethasone, VETRANAL®, analytical standard
Pricing and availability is not currently available.
Supelco
Oxibendazole, VETRANAL®, analytical standard
Pricing and availability is not currently available.
Sigma-Aldrich
Adenosine, ≥99%
Pricing and availability is not currently available.
Sigma-Aldrich
Adenosine, BioReagent, suitable for cell culture
Pricing and availability is not currently available.
Sigma-Aldrich
Dexamethasone, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Dexamethasone, powder, BioReagent, suitable for cell culture, ≥97%
Pricing and availability is not currently available.
Sigma-Aldrich
Diphenhydramine hydrochloride, ≥98% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Tamoxifen, ≥99%
Pricing and availability is not currently available.
Sigma-Aldrich
Pyridoxine, ≥98%
Pricing and availability is not currently available.
Sigma-Aldrich
Naproxen, meets USP testing specifications
Pricing and availability is not currently available.
Sigma-Aldrich
Terfenadine
Pricing and availability is not currently available.
Sigma-Aldrich
Biotin, ≥99% (HPLC), lyophilized powder
Pricing and availability is not currently available.
Sigma-Aldrich
5-Fluorocytosine, nucleoside analog
Pricing and availability is not currently available.
Sigma-Aldrich
Phentolamine methanesulfonate salt, ≥98% (TLC), powder
Pricing and availability is not currently available.
Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Piroxicam, meets USP testing specifications
Pricing and availability is not currently available.
Sigma-Aldrich
Colchicine, suitable for plant cell culture, BioReagent, ≥95% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Colchicine, ≥95% (HPLC), powder
Pricing and availability is not currently available.
Sigma-Aldrich
Captopril, ≥98% (HPLC), powder
Pricing and availability is not currently available.
Sigma-Aldrich
Oxibendazole, ~98%
Pricing and availability is not currently available.
Sigma-Aldrich
2′,3′-Dideoxycytidine, ≥98% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Clotrimazole
Pricing and availability is not currently available.
Sigma-Aldrich
L-Arginine, reagent grade, ≥98%
Pricing and availability is not currently available.
Sigma-Aldrich
Folic acid, ≥97%
Pricing and availability is not currently available.
Sigma-Aldrich
Hydrochlorothiazide, meets USP testing specifications
Pricing and availability is not currently available.